Annual accounts receivable:
$1.01B+$31.80M(+3.27%)Summary
- As of today (June 23, 2025), DXCM annual accounts receivable is $1.01 billion, with the most recent change of +$31.80 million (+3.27%) on December 31, 2024.
- During the last 3 years, DXCM annual accounts receivable has risen by +$491.40 million (+95.55%).
- DXCM annual accounts receivable is now at all-time high.
Performance
DXCM Accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly accounts receivable:
$1.16B+$149.50M(+14.87%)Summary
- As of today (June 23, 2025), DXCM quarterly accounts receivable is $1.16 billion, with the most recent change of +$149.50 million (+14.87%) on March 31, 2025.
- Over the past year, DXCM quarterly accounts receivable has increased by +$176.60 million (+18.05%).
- DXCM quarterly accounts receivable is now at all-time high.
Performance
DXCM Quarterly accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
DXCM Accounts receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +3.3% | +18.1% |
| 3 y3 years | +95.5% | +112.2% |
| 5 y5 years | +251.3% | +284.2% |
DXCM Accounts receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +95.5% | at high | +112.2% |
| 5 y | 5-year | at high | +251.3% | at high | +289.6% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
DXCM Accounts receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $1.16B(+14.9%) |
| Dec 2024 | $1.01B(+3.3%) | $1.01B(+0.4%) |
| Sep 2024 | - | $1.00B(+6.0%) |
| Jun 2024 | - | $945.20M(-3.4%) |
| Mar 2024 | - | $978.60M(+0.5%) |
| Dec 2023 | $973.90M(+36.5%) | $973.90M(+24.0%) |
| Sep 2023 | - | $785.70M(+4.7%) |
| Jun 2023 | - | $750.60M(+17.9%) |
| Mar 2023 | - | $636.80M(-10.7%) |
| Dec 2022 | $713.30M(+38.7%) | $713.30M(+26.4%) |
| Sep 2022 | - | $564.10M(+0.6%) |
| Jun 2022 | - | $560.80M(+3.0%) |
| Mar 2022 | - | $544.50M(+5.9%) |
| Dec 2021 | $514.30M(+20.0%) | $514.30M(-2.8%) |
| Sep 2021 | - | $529.10M(+9.4%) |
| Jun 2021 | - | $483.50M(+9.0%) |
| Mar 2021 | - | $443.40M(+3.5%) |
| Dec 2020 | $428.50M(+49.7%) | $428.50M(+15.8%) |
| Sep 2020 | - | $370.00M(+24.8%) |
| Jun 2020 | - | $296.50M(-1.4%) |
| Mar 2020 | - | $300.70M(+5.0%) |
| Dec 2019 | $286.30M(+26.3%) | $286.30M(+21.9%) |
| Sep 2019 | - | $234.90M(+8.1%) |
| Jun 2019 | - | $217.30M(+6.2%) |
| Mar 2019 | - | $204.70M(-9.7%) |
| Dec 2018 | $226.70M(+68.8%) | $226.70M(+33.5%) |
| Sep 2018 | - | $169.80M(+4.8%) |
| Jun 2018 | - | $162.00M(+30.8%) |
| Mar 2018 | - | $123.90M(-7.7%) |
| Dec 2017 | $134.30M(+32.1%) | $134.30M(+21.5%) |
| Sep 2017 | - | $110.50M(+8.7%) |
| Jun 2017 | - | $101.70M(+18.4%) |
| Mar 2017 | - | $85.90M(-15.5%) |
| Dec 2016 | $101.70M(+37.2%) | $101.70M(+32.4%) |
| Sep 2016 | - | $76.80M(+4.1%) |
| Jun 2016 | - | $73.80M(+9.7%) |
| Mar 2016 | - | $67.30M(-9.2%) |
| Dec 2015 | $74.10M | $74.10M(+32.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2015 | - | $55.80M(+22.6%) |
| Jun 2015 | - | $45.50M(+13.2%) |
| Mar 2015 | - | $40.20M(-5.2%) |
| Dec 2014 | $42.40M(+62.5%) | $42.40M(+35.0%) |
| Sep 2014 | - | $31.40M(+9.8%) |
| Jun 2014 | - | $28.60M(+20.2%) |
| Mar 2014 | - | $23.80M(-8.8%) |
| Dec 2013 | $26.10M(+33.8%) | $26.10M(+20.8%) |
| Sep 2013 | - | $21.60M(+22.0%) |
| Jun 2013 | - | $17.70M(+8.6%) |
| Mar 2013 | - | $16.30M(-16.4%) |
| Dec 2012 | $19.50M(+56.0%) | $19.50M(+57.8%) |
| Sep 2012 | - | $12.36M(-4.2%) |
| Jun 2012 | - | $12.90M(+2.8%) |
| Mar 2012 | - | $12.54M(+0.3%) |
| Dec 2011 | $12.50M(+87.4%) | $12.50M(+38.8%) |
| Sep 2011 | - | $9.00M(+3.6%) |
| Jun 2011 | - | $8.69M(+21.5%) |
| Mar 2011 | - | $7.16M(+7.3%) |
| Dec 2010 | $6.67M(+91.1%) | $6.67M(+30.8%) |
| Sep 2010 | - | $5.10M(+9.5%) |
| Jun 2010 | - | $4.66M(+22.6%) |
| Mar 2010 | - | $3.80M(+8.9%) |
| Dec 2009 | $3.49M(+212.2%) | $3.49M(+40.3%) |
| Sep 2009 | - | $2.49M(+20.3%) |
| Jun 2009 | - | $2.07M(+53.7%) |
| Mar 2009 | - | $1.34M(+20.3%) |
| Dec 2008 | $1.12M(+420.0%) | $1.12M(+160.6%) |
| Sep 2008 | - | $429.00K(-24.5%) |
| Jun 2008 | - | $568.00K(+76.9%) |
| Mar 2008 | - | $321.00K(+49.3%) |
| Dec 2007 | $215.00K(+79.2%) | $215.00K(+25.7%) |
| Sep 2007 | - | $171.00K(+35.7%) |
| Jun 2007 | - | $126.00K(-36.4%) |
| Mar 2007 | - | $198.00K(+65.0%) |
| Dec 2006 | $120.00K | $120.00K(+0.7%) |
| Sep 2006 | - | $119.20K(+30.4%) |
| Jun 2006 | - | $91.40K |
FAQ
- What is DexCom annual accounts receivable?
- What is the all time high annual accounts receivable for DexCom?
- What is DexCom annual accounts receivable year-on-year change?
- What is DexCom quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for DexCom?
- What is DexCom quarterly accounts receivable year-on-year change?
What is DexCom annual accounts receivable?
The current annual accounts receivable of DXCM is $1.01B
What is the all time high annual accounts receivable for DexCom?
DexCom all-time high annual accounts receivable is $1.01B
What is DexCom annual accounts receivable year-on-year change?
Over the past year, DXCM annual accounts receivable has changed by +$31.80M (+3.27%)
What is DexCom quarterly accounts receivable?
The current quarterly accounts receivable of DXCM is $1.16B
What is the all time high quarterly accounts receivable for DexCom?
DexCom all-time high quarterly accounts receivable is $1.16B
What is DexCom quarterly accounts receivable year-on-year change?
Over the past year, DXCM quarterly accounts receivable has changed by +$176.60M (+18.05%)